Project Grant R01MH137057
- Summary: Neurophysiological Correlates of Cognition Over Multi-Day Timescales in Epilepsy The National Institute of Neurological Disorders and Stroke (NINDS) awarded Massachusetts General Hospital $234,630 on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct a five-year prospective research study examining the neurophysiological basis of cognitive impairment in temporal lobe epilepsy (TLE). The research...
- This Project Grant award of $423,500.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research at The Leland Stanford Junior University (Stanford University) to study behavioral, electrophysiological, and pupil-based rhythms of attention and memory in young and older adults. The project aims to examine how feature-based attention and episodic memory performance vary with age, independent of Alzheimer's disease, by conducting a well-powered study with simultaneous...
- Grant Award Summary The University of Rochester received a $346,500 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act—Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), effective August 1, 2025 through July 31, 2027. This research project aims to develop and validate spatiotemporally optimized transcranial electrical stimulation (TES) techniques to selectively target cognitive...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) provides $1,413,807.00 to Georgia TECH Research Corp, doing business as the Office of Sponsored Programs, to conduct research on tracking the flow of attention in visual circuits across the brain. The key objectives are to: 1) Establish the neural timing of...
- This Project Grant from the National Institutes of Health National Institute on Drug Abuse will fund Neurobehavioral Research Inc. to provide network synchrony neurofeedback training and evaluation for opioid dependent individuals receiving medication assisted treatment. The $807,960 award, issued on September 30, 2021, will support 12 neurofeedback sessions over 8 weeks to train participants' brains to mimic adaptive changes in resting state brain network synchrony seen with long-term...
- This federal Project Grant award of $307,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to conduct a single, highly powered study to identify memory processes that are most sensitive to the asymptomatic, preclinical stage of Alzheimer's disease (AD) pathology. The study combines a continuous report item-location associative memory task with advanced behavioral and neural modeling to estimate subtle changes in memory precision that may differentiate healthy...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $266,541 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective May 1, 2026 through April 30, 2028. The grant funds research to quantify longitudinal changes in sleep electroencephalographic (EEG) signals and their relationship to daytime cognitive function and alertness. The research leverages existing data collected...
- Federal Project Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects, through support from the National Institute on Aging under the Aging Research program (CFDA 93.866), is conducting the first clinical investigation of personalized brain stimulation as a treatment for posterior cortical atrophy (PCA), a neurodegenerative condition most commonly caused by Alzheimer's disease. The research project, funded at $10.4 million through July 31, 2029, will...
- This Project Grant award of $910,000 from the National Science Foundation (NSF) Division of Behavioral and Cognitive Sciences supports research on the "Mechanisms of Willed Attention" at the University of California, Davis (UC Davis). This research, under the NSF's Social, Behavioral, and Economic Sciences program (CFDA 47.075), aims to investigate the brain mechanisms that enable humans to voluntarily direct their attention, especially in the absence of external cues. Using...
- This Project Grant award of $1,241,250.00 from the National Science Foundation (NSF) under the Computer and Information Science and Engineering (CFDA 47.070) program supports a collaborative research project to investigate the role of brain waves in the prefrontal cortex during categorization decision-making tasks. The project involves a close collaboration between computational and experimental neuroscientists to leverage a neural modeling framework to link macroscale oscillatory brain activity...
VALIDATION OF ELECTROPHYSIOLOGICAL BIOMARKERS ASSOCIATED WITH PERFORMANCE IN A PRECLINICAL ASSAY OF SUSTAINED ATTENTION - PROJECT SUMMARY SUSTAINED ATTENTION, THE ABILITY TO FOCUS ON AN ACTIVITY OR STIMULUS OVER TIME, IS IMPAIRED IN MANY BRAIN DISORDERS. TARGETING ATTENTIONAL DEFICITS FOR TREATMENT IS CRITICAL BECAUSE THESE SYMPTOMS ARE NEGATIVELY CORRELATED WITH FUNCTIONAL OUTCOME AND QUALITY OF LIFE. CONTINUOUS PERFORMANCE TESTS (CPTS) HAVE BEEN DESIGNED TO MEASURE SUSTAINED ATTENTION IN MULTIPLE SPECIES. SIMILAR NEURAL CIRCUITS ARE ENGAGED IN BOTH HUMANS AND MODEL ORGANISMS DURING CPT PERFORMANCE, SUPPORTING THEIR USE IN TRANSLATIONAL STUDIES THAT SCREEN FOR NOVEL THERAPEUTICS. THE PRELIMBIC CORTEX (PRL), IS INVOLVED IN BOTH CONFLICT DETECTION AND ALLOCATION OF ATTENTION TO CUES BEFORE ORIENTATION, IMPORTANT COMPONENTS IN GO/NO-GO TASKS LIKE CPTS. ELECTROENCEPHALOGRAM (EEG) STUDIES IN HUMANS SHOW THAT NEURAL ACTIVITY IN THE DORSAL ANTERIOR CINGULATE CORTEX (DACC), WHICH SHOWS FUNCTIONAL AND ANATOMICAL ANALOGY TO THE RODENT PRL, IS CORRELATED WITH TASK ENGAGEMENT AND PERFORMANCE IN THE CPT. IN THIS APPLICATION, WE OPTIMIZE THE RCPT TO DETERMINE THE EFFECT OF TARGET PERCENTAGE ON THE TIME-ON-TASK VIGILANCE DECREMENT. WE THEN EVALUATE THE OPTIMIZED CPT PARADIGM BY ASSESSING THE IMPACT OF AMPHETAMINE, A KNOWN ENHANCER OF PERFORMANCE, ON THE ELECTROPHYSIOLOGICAL CORRELATES OF BEHAVIOR. FINALLY, WE MECHANISTICALLY TEST THE ROLE OF NEURAL ACTIVITY IN THE PRL-LC CIRCUIT IN CONTROLLING BEHAVIORAL PERFORMANCE AND ELECTROPHYSIOLOGICAL CORRELATES IN THE OPTIMIZED RCPT.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $762.0k | 4/7/26 | ||
| Not listed | $114.3k | 9/22/25 | ||
| Not listed | $114.3k | 9/22/25 | ||
| Not listed | $647.7k | 4/10/25 | ||
| Not listed | $647.7k | 4/10/25 |